Cholangitis: Clinical Trials

3 trials for Cholangitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 3
Phase 22Terminated 2

Follow Cholangitis: new trials by email Literature Review of Cholangitis trials Research Report on Cholangitis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vancomycin for Primary Sclerosing Cholangitis
Vancomycin, Placebo - Primary Sclerosing Cholangitis
Phase 2 / Phase 3TerminatedElizabeth Carey1022020-01-232026-10-21
Study of Cilofexor in Adults With Primary Sclerosing Cholangitis
Cilofexor, Placebo - Primary Sclerosing Cholangitis
Phase 3TerminatedGilead Sciences4192019-03-272023-11-29
Trial of High-dose Urso in Primary Sclerosing Cholangitis
Ursodeoxycholic Acid, Placebo - Primary Sclerosing Cholangitis
Phase 2 / Phase 3TerminatedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1502002-07-012021-05-03

Narrower conditions

Cholangitis, Sclerosing (3)

Broader conditions

Bile Duct Diseases (3)  ·  Biliary Tract Diseases (3)  ·  Digestive System Diseases (3)

Interventions

Ursodeoxycholic Acid (1)  ·  Vancomycin (1)  ·  cilofexor (1)

Sponsors

Elizabeth Carey (1)  ·  Gilead Sciences (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Countries

United States (3)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  New Zealand (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Elizabeth Carey, MD (1)

Results publications

PMID 19585548, PMID 41173015, PMID 42489629

NIH funding

2019 (1), R01DK056924 (1)